GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma.

Autor: Avenel ICN; Department of Pathology, Bartholin Institute, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Ewald JD; Department of Pathology, Odense University Hospital, Odense, Denmark.; Pathology Research Unit, Department of Clinical Research, University of Southern Denmark Odense, Odense, Denmark., Ariey-Bonnet J; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; DCCC Brain Tumor Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kristensen IH; Department of Pathology, Bartholin Institute, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Petterson SA; Department of Pathology, Odense University Hospital, Odense, Denmark.; Clinical Genome Center, Department of Clinical Research, University of Southern Denmark Odense, Odense, Denmark., Thesbjerg MN; Clinical Genome Center, Department of Clinical Research, University of Southern Denmark Odense, Odense, Denmark., Burton M; Clinical Genome Center, Department of Clinical Research, University of Southern Denmark Odense, Odense, Denmark., Thomassen M; Clinical Genome Center, Department of Clinical Research, University of Southern Denmark Odense, Odense, Denmark., Wennerberg K; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; DCCC Brain Tumor Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Michaelsen SR; Department of Pathology, Bartholin Institute, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; DCCC Brain Tumor Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kristensen BW; Department of Pathology, Bartholin Institute, Rigshospitalet, Copenhagen, Denmark. bjarne.winther.kristensen.01@regionh.dk.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. bjarne.winther.kristensen.01@regionh.dk.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark. bjarne.winther.kristensen.01@regionh.dk.; DCCC Brain Tumor Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. bjarne.winther.kristensen.01@regionh.dk.

Publikováno v: Scientific reports [Sci Rep] 2024 Jul 31; Vol. 14 (1), pp. 17639. Date of Electronic Publication: 2024 Jul 31.